Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort
Open accessAbstract
Background Heterogeneity in type 2 diabetes can be represented by a tree-like graph structure by use of reversed graph-embedded dimensionality reduction. We aimed to examine whether this approach can be used to stratify key pathophysiological components and diabetes-related complications during longitudinal follow-up of individuals with recent-onset type 2 diabetes.Methods For this cohort analysis, 927 participants aged 18-69 years from the German Diabetes Study (GDS) with recent-onset type 2 diabetes were mapped onto a previously developed two-dimensional tree based on nine simple clinical and laboratory variables, residualised for age and sex. Insulin sensitivity was assessed by a hyperinsulinaemic-euglycaemic clamp, insulin secretion was assessed by intravenous glucose tolerance test, hepatic lipid content was assessed by 1 H magnetic resonance spectroscopy, serum interleukin (IL)-6 and IL-18 were assessed by ELISA, and peripheral and autonomic neuropathy were assessed by functional and clinical measures. Participants were followed up for up to 16 years. We also investigated heart failure and all-cause mortality in 794 individuals with type 2 diabetes undergoing invasive coronary diagnostics from the Ludwigshafen Risk and Cardiovascular Health (LURIC) cohort.Findings There were gradients of clamp-measured insulin sensitivity (both dimensions: p<0·0001) and insulin secretion (p dim1<0·0001, p dim2=0·00097) across the tree. Individuals in the region with the lowest insulin sensitivity had the highest hepatic lipid content (n=205, p dim1<0·0001, p dim2=0·037), pro-inflammatory biomarkers (IL-6: n=348, p dim1<0·0001, p dim2=0·013; IL-18: n=350, p dim1<0·0001, p dim2=0·38), and elevated cardiovascular risk (n events=143, p dim1=0·14, p dim2<0·00081), whereas individuals positioned in the branch with the lowest insulin secretion were more prone to require insulin therapy (n events=85, p dim1=0·032, p dim2=0·12) and had the highest risk of diabetic sensorimotor polyneuropathy (n events=184, p dim1=0·012, p dim2=0·044) and cardiac autonomic neuropathy (n events=118, p dim1=0·0094, p dim2=0·06). In the LURIC cohort, all-cause mortality was highest in the tree branch showing insulin resistance (n events=488, p dim1=0·12, p dim2=0·0032). Significant gradients differentiated individuals having heart failure with preserved ejection fraction from those who had heart failure with reduced ejection fraction.Interpretation These data define the pathophysiological underpinnings of the tree structure, which has the potential to stratify diabetes-related complications on the basis of routinely available variables and thereby expand the toolbox of precision diabetes diagnosis.Funding German Diabetes Center, German Federal Ministry of Health, Ministry of Culture and Science of the state of North Rhine-Westphalia, German Federal Ministry of Education and Research, German Diabetes Association, German Center for Diabetes Research, European Community, German Research Foundation, and Schmutzler Stiftung.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Different subtypes/endotypes/clusters of T2D are associated with different risks of disease progression, with particularly high risk for MASLD/MASH progression in individuals with severe insulin resistance.
“Different subtypes/endotypes/clusters of T2D are associated with different risks of disease progression, 58,59 with particularly high risk for MASLD/MASH progression in those individuals with severe insulin resistance.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [60]
The citation lists haven’t been fetched yet
References 35 · Cited by 58
- Authors
- Schön, M., Prystupa, K., Mori, T., Zaharia, O. P., Bódis, K., Bombrich, M., Möser, C., Yurchenko, I., Kupriyanova, Y., Strassburger, K., Bobrov, P., Nair, A. T. N., Bönhof, G. J., Strom, A., Delgado, G. E., Kaya, S., Guthoff, R., Stefan, N., Birkenfeld, A. L., Hauner, H., Seissler, J., Pfeiffer, A., Blüher, M., Bornstein, S., Szendroedi, J., Meyhöfer, S., Trenkamp, S., Burkart, V., Schrauwen-Hinderling, V. B., Kleber, M. E., Niessner, A., Herder, C., Kuss, O., März, W., Pearson, E. R., Roden, M., Wagner, R., Al-Hasani, H., Belgardt, B.-F., Bönhof, G. J., Geerling, G., Herder, C., Icks, A., Jandeleit-Dahm, K., Kotzka, J., Kuss, O., Lammert, E., Rathmann, W., Roden, M., Schlesinger, S., Schrauwen-Hinderling, V., Szendroedi, J., Trenkamp, S., & Wagner, R.
- Affiliations
- Düsseldorf University Hospital (DE)
- Deutsches Diabetes-Zentrum e.V. (DE)
- University of Dundee (GB)
- Heidelberg University (DE)
- University of Tübingen (DE)
- Technical University of Munich (DE)
- Ludwig-Maximilians-Universität München (DE)
- German Institute of Human Nutrition (DE)
- Helmholtz Munich (DE)
- Technische Universität Dresden (DE)
- German Center for Diabetes Research (DE)
- Medical University of Vienna (AT)
- ORCID
- Schön, Martin
- Prystupa, Katsiaryna
- Mori, Tim
- Zaharia, Oana P
- Bódis, Kálmán
- Kupriyanova, Yuliya
- Strassburger, Klaus
- Nair, Anand T N
- Strom, Alexander
- Delgado, Graciela E
- Guthoff, Rainer
- Stefan, Norbert
- Birkenfeld, Andreas L
- Hauner, Hans
- Seissler, Jochen
- Pfeiffer, Andreas
- Blüher, Matthias
- Bornstein, Stefan
- Meyhöfer, Svenja
- Burkart, Volker
- Kleber, Marcus E
- Niessner, Alexander
- März, Winfried
- Pearson, Ewan R
- Geerling, Gerd
- Lammert, Eckhard
- Schlesinger, Sabrina
- Venue
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Published
- 2024-02
- Volume
- 12
- Issue
- 2
- Pages
- 119-131
- ISSN
- 2213-8587 (ISSN-L)
- OpenAlex
- W4390065585
- Cited by
- 58
- References
- 35
- Citations by year
- 2026: 18 · 2025: 24 · 2024: 15 · 2023: 1
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- Licence
- Locations
- The Lancet Diabetes & Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion, cc-by-nc-nd)
- mediaTUM (Technical University of Munich) (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- German Research Foundation (GRK 2576)
- European Commission (HORIZON-HLTH-2022-STAYHLTH-02\u201301)
- German Federal Ministry of Health
- BMBF Bonn
- Ministry of Culture and Science of the State of North Rhine-Westphalia
- Schmutzler Stiftung
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- insulin sensitivity, insulin secretion, hepatic fat content, pro-inflammatory markers, interleukin-6, IL-18, peripheral neuropathy, autonomic neuropathy, heart failure, all-cause mortality, cardiovascular risk, German Diabetes Study
- MeSH terms
- Diabetes Mellitus, Type 2, Heart Failure, Humans, Insulin, Insulin Resistance, Lipids, Prospective Studies, Interleukin-18, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review